Page 29 - வெள்ளை வீடு அலுவலகம் ஆஃப் தேசிய மருந்து கட்டுப்பாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வெள்ளை வீடு அலுவலகம் ஆஃப் தேசிய மருந்து கட்டுப்பாடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வெள்ளை வீடு அலுவலகம் ஆஃப் தேசிய மருந்து கட்டுப்பாடு Today - Breaking & Trending Today

Dr. William Smith | LD 675 | Newsradio WGAN


Posted on
April 30, 2021 by dmartignetti
LD 675  (Sponsored By Troy Jackson) An Act To Protect Maine Consumers from Unsupported Price Increases on Prescription Medicines by Creating an Independent Review Process.
Dr. William S. Smith is Pioneer’s Visiting Fellow in the Life Sciences. Dr. Smith has 25 years of experience in government and in corporate roles. His career includes senior staff positions for the Republican House leadership on Capitol Hill, the White House Office of National Drug Control Policy, and the Massachusetts Governor’s office where he served under Governors Weld and Cellucci. He spent ten years at Pfizer Inc as Vice President of Public Affairs and Policy where he was responsible for Pfizer’s corporate strategies for the U.S. policy environment. He later served as a consultant to major pharmaceutical, biotechnology and medical device companies. Dr. Smith earned his PhD in political science with distinction at The Catholic University of Ame ....

United States , Capitol Hill , Williams Smith , John Baldacci , Matt Gagnon , Pfizer Inc As Vice , Catholic University Of America , Session Of Congress , White House Office Of National Drug Control , National Politics , Public Affairs , Life Sciences , William Smith , Sponsored By Troy Jackson , Unsupported Price Increases , Prescription Medicines , Independent Review , Visiting Fellow , Republican House , White House Office , National Drug Control Policy , Massachusetts Governor , Governors Weld , Pfizer Inc , Vice President , Catholic University ,

As Opioid Deaths Surge, Biden Team Moves To Make Buprenorphine Treatment Mainstream


Joe Raedle/Getty Images
toggle caption
Joe Raedle/Getty Images
The Biden administration aims to make buprenorphine, a drug proven to help people with opioid addiction, more available.
Joe Raedle/Getty Images
The Biden administration says new federal guidelines released Tuesday will allow far more medical practitioners to prescribe buprenorphine, a drug proven to reduce opioid relapses and overdose deaths.
The change lowers regulatory hurdles that critics believe sharply limit use of the life-saving medication at a time when drug deaths are surging.
We have made this much easier for physicians but also for other medical practitioners, said Dr. Rachel Levine, assistant secretary of health, speaking with NPR. ....

United States , Patrice Harris , Yngvild Olsen , Tom Coderre , Regina Labelle , Joe Raedle Getty , Keith Humphreys , Rachel Levine , Centers For Disease , White House Office Of National Drug Control , American Medical Association , American Society Of Addiction Medicine , Stanford University , Mental Health Administration , Getty Images , Substance Abuse , Mental Health , Disease Control , White House Office , National Drug Control Policy , Trump White House , American Society , Addiction Medicine , ஒன்றுபட்டது மாநிலங்களில் , பேட்ரீஸ் ஹாரிஸ் , டோம் கொடேற்ரே ,